More radionuclide therapy is better for prostate cancer patients, study suggests
by Zangani • 10 November 2011 • Pain News
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research.